Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Venous Thromboembolism Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02555878
What this trial is testing

Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer Participants

Who this might be right for
Neoplasms
Janssen Research & Development, LLC 841
Early research (Phase 1)Study completedNCT02864810
What this trial is testing

Safety, Pharmacokinetics, Biodistribution, and Diagnostic Performance of [18F]GP1 PET in Thromboembolism

Who this might be right for
Thromboembolism
Asan Foundation 32
Not applicableStudy completedNCT04477564
What this trial is testing

Clonal Hematopoiesis of Indeterminate Potential in Venous Thromboembolism

Who this might be right for
Venous Thromboembolism
Centre Hospitalier Universitaire de Nīmes 150
Not applicableStudy completedNCT04359212
What this trial is testing

Increased Risk of VTE and Higher Hypercoagulability in Patients Recovered in ICU and in Medical Ward for COVID-19

Who this might be right for
COVID-19 DiseaseThromboembolism, Venous
Quovadis Associazione 90
Not applicableStudy completedNCT01428544
What this trial is testing

Special Drug Use Investigation (Retrospective) for Arixtra® (Fondaparinux) Venous Thromboembolism Treatment (Over 100kg)

Who this might be right for
Ataxia
GlaxoSmithKline 5
Post-approval studies (Phase 4)Study completedNCT00077753
What this trial is testing

EXCLAIM:Extended Prophylaxis for Venous ThromboEmbolism (VTE) in Acutely Ill Medical Patients With Prolonged Immobilization

Who this might be right for
Venous Thromboembolism
Sanofi 4,726
Not applicableUnknownNCT03773939
What this trial is testing

Risk Prediction of Venous Thromboembolism in Critically Ill

Who this might be right for
Venous ThrombosisCritical Illness
University Medical Center Groningen 5,400
Not applicableStudy completedNCT06606275
What this trial is testing

The Safety and Effectiveness of Warfarin Vs Apixaban in Patients With NVAF/ VTE and ESKD on Dialysis

Who this might be right for
End-Stage Kidney Disease (ESKD)Non-valvular Atrial Fibrillation (NVAF)Venous Thromboembolism (VTE)
Abu Dhabi Health Services Company 67
Not applicableLooking for participantsNCT04211181
What this trial is testing

CHIPs-VTE Study in Hospitalized Patients to Prevent Hospital-Acquired Venous Thromboembolism

Who this might be right for
Venous Thromboembolic DiseasePulmonary EmbolismVenous Thromboembolism+2 more
China-Japan Friendship Hospital 5,800
Not applicableStudy completedNCT05464901
What this trial is testing

VTE and the Related Factors Associated With Higher Rates of PE After a DVT in Southwestern China

Who this might be right for
Venous Thromboembolism; Deep Vein Thrombosis; Pulmonary Embolism; Anticoagulants
Wei Huang 500
Not applicableStudy completedNCT03214172
What this trial is testing

Characterizing Recurrent Thromboembolism, Major Bleeding and All-Cause Death in Patients With Cancer-Associated Thromboembolism Treated With Rivaroxaban

Who this might be right for
Venous Thromboembolism
Bayer 1,000
Large-scale testing (Phase 3)Study completedNCT02064439
What this trial is testing

Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism)

Who this might be right for
Pulmonary EmbolismThromboembolismThrombosis+2 more
Bayer 3,365
Not applicableStudy completedNCT04141228
What this trial is testing

Hospital Healthcare Use and Cost in Patients in the Hospital With a Venous Thromboembolism (VTE) Treated With Apixaban or Warfarin in the US

Who this might be right for
Venous Thromboembolism (VTE)
Bristol-Myers Squibb 28,000
Testing effectiveness (Phase 2)Study completedNCT02923115
What this trial is testing

Study to Assess the Safety, Pharmacokinetics/Dynamics of DS-1040b in Subjects With Acute Submassive Pulmonary Embolism

Who this might be right for
Pulmonary EmbolismThrombotic Disease
Daiichi Sankyo 134
Not applicableStudy completedNCT00853463
What this trial is testing

Discharge ALERT: Quality Improvement Initiative

Who this might be right for
Pulmonary EmbolismDeep Vein ThrombosisProphylaxis+2 more
Brigham and Women's Hospital 2,515
Large-scale testing (Phase 3)Looking for participantsNCT04257487
What this trial is testing

Sulodexide, VESSEL®, for the Prevention of Recurrent Venous Thromboembolism (The Jason Study)

Who this might be right for
Venous ThromboembolismAnticoagulantElderly
Arianna Anticoagulazione Foundation 1,455
Not applicableStudy completedNCT02425345
What this trial is testing

Women's Health Initiative Strong and Healthy Study

Who this might be right for
Myocardial InfarctionStrokeCardiovascular Mortality+11 more
Fred Hutchinson Cancer Center 49,331
Not applicableStudy completedNCT01869075
What this trial is testing

Toronto Thromboprophylaxis Patient Safety Initiative

Who this might be right for
Venous Thromboembolism
Sunnybrook Health Sciences Centre 1,895
Post-approval studies (Phase 4)UnknownNCT01916707
What this trial is testing

Weight Based Enoxaparin in Trauma Patients

Who this might be right for
Venous Thromboembolism
Intermountain Health Care, Inc. 1,200
Large-scale testing (Phase 3)Study completedNCT02984384
What this trial is testing

PREVENTion of Clot in Orthopaedic Trauma

Who this might be right for
Blood ClotTrauma
Major Extremity Trauma Research Consortium 12,424
Next Page